A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency

This study has been completed.
Sponsor:
Collaborators:
Teva Pharmaceutical Industries
TransPharma Medical
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Teva Neuroscience, Inc. )
ClinicalTrials.gov Identifier:
NCT00455260
First received: April 2, 2007
Last updated: August 30, 2013
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)